Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.

Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.

Although growth hormone (GH) replacement therapy is increasingly utilized in the management of adult hypopituitary patients, optimum dosing schedules are poorly defined. The use of weight-based or surface area-based dosing may result in overtreatment, and individual variation in susceptibility on th...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Drake, WM, Coyte, D, Camacho-Hübner, C, Jivanji, N, Kaltsas, G, Wood, D, Trainer, P, Grossman, AB, Besser, G, Monson, J
التنسيق:	Journal article
اللغة:	English
منشور في:	1998

مواد مشابهة

Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
حسب: Florakis, D, وآخرون
منشور في: (2000)

Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply
حسب: Monson, J, وآخرون
منشور في: (2001)

Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.
حسب: Frajese, G, وآخرون
منشور في: (2001)

Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
حسب: Chung, T, وآخرون
منشور في: (2008)

Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
حسب: Agha, A, وآخرون
منشور في: (2007)

Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years.
حسب: le Roux, C, وآخرون
منشور في: (2002)

Role of fasting plasma glucose, glycated haemoglobin and homeostatic model assessment in the detection of glucose intolerance in adult hypopituitary patients during growth hormone replacement therapy.
حسب: Colson, A, وآخرون
منشور في: (2008)

Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
حسب: Chung, T, وآخرون
منشور في: (2005)

Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
حسب: Kaltsas, G, وآخرون
منشور في: (2001)

Insulin-like growth factor-I and- II in combination inhibit the release of growth hormone-releasing hormone from the rat hypothalamus in vitro.
حسب: Korbonits, M, وآخرون
منشور في: (1996)

The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults.
حسب: Sverrisdóttir, Y, وآخرون
منشور في: (2003)

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration.
حسب: Jenkins, P, وآخرون
منشور في: (2000)

Growth hormone deficiency and replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density.
حسب: Colson, A, وآخرون
منشور في: (2006)

The modulation of platelet function by growth hormone in growth hormone deficient Hypopituitary patients
حسب: Irene K Oglesby, وآخرون
منشور في: (2023-09-01)

The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
حسب: Korbonits, M, وآخرون
منشور في: (1999)

Hexarelin as a test of pituitary reserve in patients with pituitary disease.
حسب: Korbonits, M, وآخرون
منشور في: (1999)

Pyridostigmine partially reverses dexamethasone-induced inhibition of the growth hormone response to growth hormone-releasing hormone.
حسب: Trainer, P, وآخرون
منشور في: (1992)

Authors' response: The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women
حسب: Kaltsas, G, وآخرون
منشور في: (2003)

The prevalence and characteristic features of cyclicity and variability in Cushing's disease.
حسب: Alexandraki, K, وآخرون
منشور في: (2009)

How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
حسب: Kaltsas, G, وآخرون
منشور في: (2000)

Classic cardiovascular risk factors improve in very elderly hypopituitary patients treated on standard hormone replacement in long term follow- up
حسب: Isabella Naves Rosa, وآخرون
منشور في: (2021-03-01)

CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing's syndrome.
حسب: Sohaib, SA, وآخرون
منشور في: (1999)

Complications of inferior petrosel sinus sampling.
حسب: Kaltsas, G, وآخرون
منشور في: (2000)

Circulating Levels of Irisin in Hypopituitary and Normal Subjects.
حسب: Lara Pena-Bello, وآخرون
منشور في: (2016-01-01)

Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome.
حسب: Korbonits, M, وآخرون
منشور في: (1995)

Prevalence and risk factors of the metabolic syndrome in young adults with childhood-onset hypopituitary growth hormone deficiency
حسب: Han Hyuk Lim, وآخرون
منشور في: (2010-10-01)

Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy.
حسب: Swords, F, وآخرون
منشور في: (2009)

The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors.
حسب: Kaltsas, G, وآخرون
منشور في: (1998)

Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
حسب: Isidori, A, وآخرون
منشور في: (2003)

Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients
حسب: Hugo L. Fideleff, وآخرون
منشور في: (2016-02-01)

Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
حسب: Newell-Price, J, وآخرون
منشور في: (2002)

NITRIC-OXIDE AS A NOVEL REGULATOR OF NEUROENDOCRINE FUNCTION - CONTROL OF CORTICOTROPIN-RELEASING HORMONE-41 RELEASE FROM THE RAT HYPOTHALAMUS INVITRO
حسب: Costa, A, وآخرون
منشور في: (1992)

Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
حسب: Korbonits, M, وآخرون
منشور في: (1998)

A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.
حسب: Miraki-Moud, F, وآخرون
منشور في: (2005)

A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome.
حسب: Kaltsas, G, وآخرون
منشور في: (1999)

Initial response of young people with thyrotoxicosis to block and replace or dose titration thionamide
حسب: Claire L Wood, وآخرون
منشور في: (2023-01-01)

Clinical, radiological and pathological features of patients with Rathke's cleft cysts: tumors that may recur.
حسب: Mukherjee, J, وآخرون
منشور في: (1997)

BENZODIAZEPINES ATTENUATE THE SERUM CORTISOL RESPONSE TO CORTICOTROPIN-RELEASING HORMONE (CRH) IN HEALTHY-VOLUNTEERS
حسب: Trainer, P, وآخرون
منشور في: (1992)

No clear evidence for an association between GH replacement and relapse of intracranial germ cell tumours: single centre and KIMS experience.
حسب: Chung, T, وآخرون
منشور في: (2010)

Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro.
حسب: Costa, A, وآخرون
منشور في: (1993)